SkinBioTherapeutics will "continue to be flexible enough to adapt to opportunities"

Digital Asset Direct by SkinBioTherapeutics PLC

London, UK | December 19, 2022 06:14 AM Eastern Standard Time

SkinBioTherapeutics PLC (AIM:SBTX) chief executive Stuart Ashman speaks to Proactive after announcing the raising of £2.5mln via a placing of new shares. He reveals what the company intends to do with the new funding, that may be augmented by a further £1mln from a retail offer. Ashman says that SkinBioTherapeutics "has always been and always will continue to be flexible enough to adapt to opportunities as and when they come [its] way."

Contact Details

Proactive

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com